reference/21967633

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21967633

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, U.S. Gov't, P.H.S.
endingPage	73
issn	1078-0432
issueIdentifier	9
pageRange	3766-73
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	3766
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c869a8794c5f4e8881585fb730ebef25 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_24893d8a1064ff755fbb5c20ca4f4b6a
bibliographicCitation	Zeng S, Chen YZ, Fu L, Johnson KR, Fan W. In vitro evaluation of schedule-dependent interactions between docetaxel and doxorubicin against human breast and ovarian cancer cells. Clin Cancer Res. 2000 Sep;6(9):3766–73. PMID: 10999771.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7d117481dcf2ee16ccec20d94cc96ca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e43a869c51d14fff577079897ad43769 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c7e64d09bfb7970e47724171c8d2ab7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95272cdd5ad4d416e1874c05f925e0b3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fae6575128ffe2c5ac0ca3a485f649da
date	200009
identifier	https://pubmed.ncbi.nlm.nih.gov/10999771
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1078-0432
language	English
source	https://pubmed.ncbi.nlm.nih.gov/
title	In vitro evaluation of schedule-dependent interactions between docetaxel and doxorubicin against human breast and ovarian cancer cells
discusses	http://id.nlm.nih.gov/mesh/M0029578 http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0026156 http://id.nlm.nih.gov/mesh/M0028673 http://id.nlm.nih.gov/mesh/M0184558 http://id.nlm.nih.gov/mesh/M0443608
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000008 http://id.nlm.nih.gov/mesh/D017239Q000031 http://id.nlm.nih.gov/mesh/D010051Q000188 http://id.nlm.nih.gov/mesh/D001943Q000188 http://id.nlm.nih.gov/mesh/D043823
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D014407 http://id.nlm.nih.gov/mesh/D000971Q000494 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D010051Q000473 http://id.nlm.nih.gov/mesh/D008938Q000187 http://id.nlm.nih.gov/mesh/D001943Q000473 http://id.nlm.nih.gov/mesh/D000077143 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D019253Q000378 http://id.nlm.nih.gov/mesh/D004317Q000008 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D019908Q000378 http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D010766Q000187 http://id.nlm.nih.gov/mesh/D017239Q000008 http://id.nlm.nih.gov/mesh/D053938Q000187 http://id.nlm.nih.gov/mesh/D004347 http://id.nlm.nih.gov/mesh/D017239Q000037
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4f3366af2ce1555e259faab86aad3bef http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8368eabbeab9b8d61c10bf2480f1aedd http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64965 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8752 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Total number of triples: 62.